We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Building Better Bacteriophage
News

Building Better Bacteriophage

Building Better Bacteriophage
News

Building Better Bacteriophage

Credit: Pixabay.
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Building Better Bacteriophage"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Researchers are pursuing engineered bacteriophage as alternatives to antibiotics to infect and kill multi-drug resistant bacteria. The potential for an innovative synthetic biology approach to enhance phage therapeutics and the role a biofoundry can play in making this approach feasible and effective is discussed in an article in PHAGE: Therapy, Applications, and Research, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers launching in early 2020. Click here to read the full-text article free on the PHAGE website through December 21, 2019.

The article entitled “Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria” was coauthored by Karen Weynberg, PhD, The University of Queensland (St. Lucia) and CSIRO Future Science Platform (Brisbane) and Paul Jaschke, PhD, Macquarie University (Sydney), Australia. The authors discuss the promise of phage therapy as a radical alternative to antibiotics, and the use of synthetic biology to engineer novel phage with desirable characteristics. They also describe the emerging use of cutting-edge facilities called biofoundries, in which automated, high-throughput laboratory processes can accelerate the bioengineering, modification, and selection of bacteriophage, making their development more effective and cost-efficient.


“This article nicely summarizes the state-of-the-art in terms of using molecular biology to create ‘next-generation phages,’” says Martha Clokie, PhD, Editor-in-Chief of PHAGE and Professor of Microbiology, University of Leicester (U.K.). “Once we have understood the biology of these organisms, the sky is possibly the limit in terms of how we can engineer them to make them even more attuned to specific purposes.”

Reference
Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria. Karen D. Weynberg and Paul R. Jaschke. Phage, 5 Nov 2019, https://doi.org/10.1089/phage.2019.0005.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement